{
  "scenario_id": "biotech_bioethics_frameworks_2025",
  "context": "Biotechnology company developing CRISPR-based gene therapies, facing ethical dilemmas in clinical applications",
  "stakeholders": {
    "requester": "Chief Scientific Officer",
    "approvers": [
      "CEO",
      "Board of Directors",
      "Ethics Committee Chair"
    ],
    "influencers": [
      "Patient Advocacy Groups",
      "Regulatory Agencies",
      "Scientific Community"
    ]
  },
  "request": {
    "amount": "$50 million",
    "purpose": "Establish comprehensive bioethics framework for gene editing research and clinical applications",
    "urgency": "high",
    "justification": "Regulatory landscape evolving rapidly; proactive ethical framework needed to maintain public trust and regulatory compliance"
  },
  "decision_process": [
    {
      "stage": "ethical_review",
      "duration": "4 weeks",
      "activities": [
        "Stakeholder consultations",
        "Ethical dilemma analysis",
        "Regulatory landscape assessment"
      ],
      "outcome": "Framework development approved with enhanced oversight requirements"
    },
    {
      "stage": "framework_design",
      "duration": "8 weeks",
      "activities": [
        "Expert panel formation",
        "Policy development",
        "Implementation planning"
      ],
      "outcome": "Comprehensive bioethics framework established"
    },
    {
      "stage": "pilot_implementation",
      "duration": "6 weeks",
      "activities": [
        "Framework testing",
        "Stakeholder feedback",
        "Refinement process"
      ],
      "outcome": "Framework validated and ready for company-wide adoption"
    }
  ],
  "business_impact": {
    "expected_outcomes": [
      "Enhanced regulatory compliance",
      "Improved public trust",
      "Competitive advantage in ethical gene therapies"
    ],
    "projected_revenue": "N/A (compliance investment)",
    "risk_factors": [
      "Implementation costs",
      "Regulatory changes",
      "Public perception challenges"
    ]
  }
}